GR900100280A - Αντιμυκητικα μεσα αζωλης υπο μορφην αεροζολ. - Google Patents

Αντιμυκητικα μεσα αζωλης υπο μορφην αεροζολ.

Info

Publication number
GR900100280A
GR900100280A GR900100280A GR900100280A GR900100280A GR 900100280 A GR900100280 A GR 900100280A GR 900100280 A GR900100280 A GR 900100280A GR 900100280 A GR900100280 A GR 900100280A GR 900100280 A GR900100280 A GR 900100280A
Authority
GR
Greece
Prior art keywords
antifungal
azole
inhalation
formulation
aerosolized
Prior art date
Application number
GR900100280A
Other languages
Greek (el)
English (en)
Inventor
Campbell Samuel Thomas Dr Orr
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of GR900100280A publication Critical patent/GR900100280A/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
GR900100280A 1989-04-12 1990-04-10 Αντιμυκητικα μεσα αζωλης υπο μορφην αεροζολ. GR900100280A (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898908250A GB8908250D0 (en) 1989-04-12 1989-04-12 Formulations

Publications (1)

Publication Number Publication Date
GR900100280A true GR900100280A (el) 1991-09-27

Family

ID=10654880

Family Applications (1)

Application Number Title Priority Date Filing Date
GR900100280A GR900100280A (el) 1989-04-12 1990-04-10 Αντιμυκητικα μεσα αζωλης υπο μορφην αεροζολ.

Country Status (7)

Country Link
EP (1) EP0467916A1 (pt)
JP (1) JPH04504419A (pt)
CA (1) CA2014401A1 (pt)
GB (1) GB8908250D0 (pt)
GR (1) GR900100280A (pt)
PT (1) PT93739A (pt)
WO (1) WO1990011754A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8055691A (en) * 1990-06-29 1992-01-23 Fisons Plc Pressurised aerosol compositions
CZ271393A3 (en) 1991-06-10 1994-07-13 Schering Corp Aerosol preparations without chlorofluorinated hydrocarbons
IT1253711B (it) * 1991-12-17 1995-08-23 Alfa Wassermann Spa Formulazioni farmaceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
CA2117651C (en) * 1992-03-18 2006-01-03 Jan Heeres Itraconazole and saperconazole stereoisomers
EP0680324A4 (en) * 1993-01-27 1996-04-10 Sepracor Inc METHODS AND COMPOSITIONS USING (2R, 4S) ITRACONAZOLE.
DE4323636A1 (de) * 1993-07-15 1995-01-19 Hoechst Ag Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung
JP2875140B2 (ja) * 1993-08-16 1999-03-24 明治製菓株式会社 抗ｍｒｓａ組成物
NL1006103C2 (nl) * 1997-05-21 1998-11-25 Nutricia Nv Huidspray op poederbasis.
DE69725476T2 (de) 1997-12-09 2004-07-22 The Goodyear Tire & Rubber Co., Akron Luftreifen mit einem transponder und einer ringförmigen antenne und verfahren zur herstellung eines derartigen reifens
DE69808670T2 (de) 1997-12-31 2003-07-03 Choongwae Pharma Corp Herstellungsverfahren und zusammensetzung einer oralen zubereitung von itraconazol
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
CA2432319A1 (en) 2000-12-21 2002-07-18 Nektar Therapeutics Pulmonary delivery of polyene antifungal agents
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
EP1789018A1 (en) * 2004-08-27 2007-05-30 The Dow Chemical Company Enhanced delivery of drug compositions to treat life threatening infections
PL2425820T3 (pl) 2007-02-11 2015-08-31 Map Pharmaceuticals Inc Sposób terapeutycznego stosowania dhe w celu umożliwienia szybkiego złagodzenia migreny przy jednoczesnym zminimalizowaniu profilu działań niepożądanych
WO2008124131A1 (en) * 2007-04-05 2008-10-16 The John Hopkins University Antifungal agents as neuroprotectants
CA2720849A1 (en) * 2008-04-15 2009-10-22 Schering Corporation High density compositions containing posaconazole and formulations comprising the same
EP2601973A1 (en) 2011-12-09 2013-06-12 Laboratoires SMB SA Dry powder formulation of azole derivative for inhalation
WO2014106727A1 (en) 2013-01-03 2014-07-10 Vectura Limited Inhaler and formulation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0156508A1 (en) * 1984-02-23 1985-10-02 Ortho Pharmaceutical Corporation Antifungal aerosol solution
EP0320002A1 (en) * 1987-12-10 1989-06-14 Kyorin Seiyaku Kabushiki Kaisha Inhalant

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0156508A1 (en) * 1984-02-23 1985-10-02 Ortho Pharmaceutical Corporation Antifungal aerosol solution
EP0320002A1 (en) * 1987-12-10 1989-06-14 Kyorin Seiyaku Kabushiki Kaisha Inhalant

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BIOLOGICAL ABSTRACTS, vol. 74, no. 3, 1987, abstract no. 15685, Biological Abstract, Inc., Philadelphia, PA, US; W.V.R. SHELLOW: "2 Percent miconazole nitrate powder in aerosol spray form: Efficacy in treating tinea pedis", & J. INT. MED. RES. 10(1): 28-31 *
BIOLOGICAL ABSTRACTS, vol. 88, no. 10, 1989, abstract no. 105355, Biological Abstracts, Inc., Philadelphia, PA, US; J. VAN CUTSEM et al.: "The treatment of experimental aspergillosis with enilconazole and itraconazole", & BULL. SOC. FR. MYCOL. MED. 18(1): 55-60 *
CLAIMS SEARCHED: ALL *

Also Published As

Publication number Publication date
PT93739A (pt) 1990-11-20
EP0467916A1 (en) 1992-01-29
JPH04504419A (ja) 1992-08-06
CA2014401A1 (en) 1990-10-12
WO1990011754A1 (en) 1990-10-18
GB8908250D0 (en) 1989-05-24

Similar Documents

Publication Publication Date Title
GR900100280A (el) Αντιμυκητικα μεσα αζωλης υπο μορφην αεροζολ.
ATE134509T1 (de) Fluorchlorkohlenwasserstoffreie aerosolformulierungen
DE69205177D1 (de) Pharmazeutische Aerosolformulierung.
DE69233690D1 (de) Abgabevorrichtung für nebelförmige Medikamente
EE03222B1 (et) Inhaleeritavad ravimpreparaadid, protsess nende valmistamiseks ja seade nende kasutamiseks
TR200002692T2 (tr) Aerosol haline getirilen aktif maddenin verilmesi.
ATE308317T1 (de) Zubereitungen mit einem anticholinergischen wirkstoff für die behandlung der chronischen obstruktiven lungenerkrankung
CA2058428A1 (en) Analgesic formulations
GEP20012462B (en) Composition for Aerosol Inhaler, Aerosol Inhaler and Method for Filling with the Composition
IL101056A (en) Composition for nasal treatment
ES2185452A1 (es) Composicion farmaceutica de fluoxetina en comprimido dispersable recubierto y su proceso de fabricacion.
IE894049L (en) Therapeutically active substituted benzimidazole and process¹for its preparation
NZ334112A (en) Aerosol formulation comprising 1,1,1,2,3,3,3-heptafluoropropane, mometasone furoate and ethanol
SE9403389D0 (sv) Pharmaceutical composition containing derivattves of sex hormones
NO20034873L (no) Aerosolformuleringer inneholdende estere av 3,17-dihydroksy degree stratrienderivater for pulmonar avlevering